Table 4: Multiple linear regression analysis for the associations between participant characteristics and HbA1c.
|
HbA1c Adjusted R2 = 0.128 |
|||
|
Variable |
Beta (unstandardized coefficient) |
P value* |
95% CI |
|
Age |
-0.008 |
0.659 |
-0.049-0.029 |
|
Diabetes Duration |
0.010 |
0.368 |
-0.012-0.033 |
|
Waist Circumference |
0.003 |
0.682 |
-0.011-0.017 |
|
MUST Score |
-0.100 |
0.765 |
-0.756-0.557 |
|
GLP-1 |
-0.250 |
0.196 |
-0.630-0.130 |
|
Insulin use |
0.559 |
0.007 |
0.155-0.964 |
|
Retinopathy |
0.021 |
0.907 |
-0.336-0.378 |
|
Neuropathy |
0.346 |
0.129 |
-0.102-0.794 |
|
Nephropathy |
0.039 |
0.858 |
-0.393-0.472 |
|
LDL-C |
0.004 |
0.109 |
-0.001-0.009 |
|
HDL-C |
-0.004 |
0.504 |
-0.016-0.008 |
|
Vitamin D |
-0.018 |
0.005 |
-0.031- -0.006 |
|
Bariatric Surgery |
-1.158 |
0.055 |
-2.342-0.027 |
|
Sulphonyl urea |
0.306 |
0.063 |
-0.017-0.630 |
|
SGLT2 |
0.257 |
0.283 |
-0.215-0.730 |
|
Biguanides |
-0.145 |
0.604 |
-0.695-0.405 |
|
TZDs |
0.412 |
0.158 |
-0.161-0.985 |
|
DPP4 |
0.252 |
0.195 |
-0.130-0.635 |
|
Creatinine Urine |
-0.001 |
0.489 |
-0.004-0.002 |
|
Sarcopenia |
0.019 |
0.359 |
-0.022-0.060 |